Detailed Information

Cited 15 time in webofscience Cited 15 time in scopus
Metadata Downloads

Blood Transfusion for Elderly Patients with Hip Fracture: a Nationwide Cohort Studyopen accessBlood Transfusion for Elderly Patients with Hip Fracture: a Nationwide Cohort Study

Other Titles
Blood Transfusion for Elderly Patients with Hip Fracture: a Nationwide Cohort Study
Authors
Jang, Suk-YongCha, Yong-HanYoo, Jun-ILOh, TaehoKim, Jung-TaekPark, Chan HoChoy, Won-SikHa, Yong-ChanKoo, Kyung-Hoi
Issue Date
21-Sep-2020
Publisher
대한의학회
Keywords
Blood Transfusion; Elderly; Hip Fracture; Mortality; Packed Red Blood Cells
Citation
Journal of Korean Medical Science, v.35, no.37, pp 1 - 10
Pages
10
Indexed
SCIE
SCOPUS
KCI
Journal Title
Journal of Korean Medical Science
Volume
35
Number
37
Start Page
1
End Page
10
URI
https://scholarworks.gnu.ac.kr/handle/sw.gnu/6176
DOI
10.3346/jkms.2020.35.e313
ISSN
1011-8934
1598-6357
Abstract
Background: This nationwide study aimed to investigate the blood transfusion status of elderly hip fracture patients and to examine the effect of packed red blood cell transfusion on all-cause mortality. Methods: From the Korean National Health Insurance Service-Senior cohort consisting of 588,147 participants aged over 60 years in 2002, a total of 14,744 new-onset hip fracture patients aged 65-99 years were followed up for 11 years. The adjusted hazard ratios (aHRs), risk ratios, and their 95% confidence intervals were estimated by the Cox proportional hazard model and Poisson regression model. Results: There were 10,973 patients (74.42%) in the transfusion group and 3,771 (25.58%) patients in the non-transfusion group. The mean volume of blood transfusion was 1,164.51 mL (+/- 865.25; median, 800 mL; interquartile range, 640-1,440). In the multivariable-adjusted Cox proportional hazard model, the transfusion group had 1.34-fold more risk of all-cause mortality than the non-transfusion group (aHR, 1.34; 95% confidence interval [CI], 1.26-1.42). In the multivariate-adjusted Poisson regression model, hip fracture patients in the transfusion group were 1.43 (adjusted risk ratio [aRR], 1.43; 95% CI, 1.09-1.87; P = 0.009) folds more likely to die within 30 days than those in the non-transfusion group. The mortality risk was highest at 90 days (aRR, 1.64; 95% CI, 1.40-1.93; P < 0.001) and slightly decreased at 180 days (aRR, 1.58; 95% CI, 1.40-1.79; P < 0.001) and 1 year (aRR, 1.43; 95% CI, 1.31-1.58; P < 0.001). Conclusion: In this nationwide representative cohort study, blood transfusion was performed in 75% of hip fracture patients. Even after adjusting for comorbidity and anticoagulant use, the postoperative results (hospitalization, mortality) of the transfusion group did not show significantly worse results than the non-transfusion group. Therefore, adequate patient blood management can only improve the patient's outcome after hip fracture surgery.
Files in This Item
There are no files associated with this item.
Appears in
Collections
College of Medicine > Department of Medicine > Journal Articles

qrcode

Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.

Altmetrics

Total Views & Downloads

BROWSE